Exercise and nutrition for ovarian cancer on PARP inhibitors
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether a supervised exercise program combined with nutrition counseling can help women with advanced ovarian cancer who are taking PARP inhibitor maintenance therapy. It aims to improve quality of life and physical function during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have high-grade serous or endometrioid ovarian, primary peritoneal, or fallopian tube cancer.
- You are currently taking a PARP inhibitor as maintenance therapy after first-line chemotherapy, and you started it at least 4 weeks ago.
- Your cancer is stage III or IV (advanced), and your doctor expects you to live at least 6 more months.
- You are physically able to exercise (no major heart, lung, or bleeding issues) and willing to follow the program.
- You have not had a recurrence of ovarian cancer and are not pregnant or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise and lifestyle (diet and activity) program can help women with ovarian or endometrial cancer during chemotherapy. You may be assigned to the lifestyle program or usual care to compare outcomes.
This study looks at how diet affects outcomes in people with ovarian cancer who are taking PARP inhibitors after initial treatment. Participation involves completing a food frequency questionnaire.
This trial tests a special exercise program during chemotherapy before surgery. It may help patients with certain gynecologic cancers get stronger and better prepared for treatment.
This trial tests whether patients preparing for ovarian cancer surgery can safely use an exercise and nutrition program beforehand to improve strength and recovery. The study helps doctors understand the best way to deliver this type of preparation.
This trial tests whether supervised exercise (before surgery) can help people with advanced ovarian cancer get ready for treatment. It’s meant to improve readiness and safety during the time leading up to surgery.
This study looks for specific gene mutations in the blood of ovarian cancer patients who have a BRCA mutation and are starting first-line maintenance therapy with a PARP inhibitor called Olaparib. It aims to better understand how these mutations may affect treatment response.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.